General Information:

Id: 906 (click here to show other Interactions for entry)
Diseases: Diabetes mellitus, type II - [OMIM]
Insulin resistance
Rattus norvegicus
SirT1 ASO: knockdown of SirT1 expression in liver and adipose tissue, diabetic via initial streptozotocin injection and 4 weeks of fructose- and high-fat-feeding
Reference: Erion DM et al.(2009) SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats. Proc. Natl. Acad. Sci. U.S.A. 106 [PMID: 19549853]

Interaction Information:

Comment SirT1 ASO down-regulated liver X receptor alpha (LXRalpha) transcription, an important factor in cholesterol transport and metabolism. Accordingly, the LXRalpha transcriptional target HDL uptake receptor (SR-B1) was also down-regulated.
Formal Description
Interaction-ID: 5454



affects_expression of



if SIRT1 is knocked down in liver and white adipose tissue of diabetic rats
Drugbank entries Show/Hide entries for SCARB1